Characterisation of a novel TSC2 missense mutation in the GAP related domain associated with minimal clinical manifestations of tuberous sclerosis
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Tuberous sclerosis (TSC) is an autosomal dominant disorder caused by mutations in either the TSC1 or TSC2 gene. Both genes are tumour suppressor genes and encode the proteins hamartin and tuberin, respectively. Recent work has established that tuberin and hamartin interact to form a complex, and that this tuberin-hamartin complex antagonises signal transduction by preventing the activation of p70 S6 kinase, either directly or through mTOR.1–3 The inhibition of p70 S6 kinase activity results in the dephosphorylation of ribosomal protein S6 and consequently leads to the down-regulation of cell growth.4,5 The clinical manifestations of TSC vary considerably between and within families. The phenotypic spectrum ranges from minor, asymptomatic skin affections, such as hypomelanotic macules, to drug resistant epilepsy, mental retardation, and increased morbidity due to cardiac tumours, cerebral astrocytomas, renal insufficiency, and lung affections.6 Although some studies suggest that TSC1 mutations are more often associated with less severe disease, considerable overlap exists in the phenotypic spectrum associated with TSC1 and TSC2 mutations.7–9 Mutations that lead to truncation of tuberin or hamartin are clearly inactivating. However, nucleotide changes that result in amino acid substitutions may be either pathogenic or, alternatively, polymorphisms that do not disrupt tuberin or hamartin function and do not cause TSC. Investigations into the effect of amino acid substitutions on tuberin can help identify important functional domains and residues, and indicate whether putative mutations are likely to be pathogenic, either by disrupting the tuberin-hamartin complex,10,11 or by preventing the inhibition of S6 phosphorylation.12 We report on a family with mild signs of TSC, segregating a novel missense mutation in exon 36 of the TSC2 gene that affects tuberin function. Although the entire GAP related domain of tuberin seems to be a target for missense mutations,13 only few …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification and characterization of the tuberous sclerosis gene on chromosome 16
(1993) · Cell · doi:10.1016/0092-8674(93)90618-z · Cited by 1,645
Tee, A. R., Fingar, D. C., Manning, B. D., Kwiatkowski, D. J., Cantley, L. C., & Blenis, J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202476899 · Cited by 827
Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products
van Slegtenhorst, M. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.6.1053 · Cited by 565
Cited by
Regulation of Small GTPases by GEFs, GAPs, and GDIs
Cherfils, J., & Zeghouf, M. (2013) · Physiological Reviews · doi:10.1152/physrev.00003.2012 · Cited by 1,245
Curatolo, P., Bombardieri, R., & Jozwiak, S. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61279-9 · Cited by 1,088
Neurological and neuropsychiatric aspects of tuberous sclerosis complex
Curatolo, P., Moavero, R., & de Vries, P. J. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00069-1 · Cited by 600
The tuberous sclerosis complex proteins – a GRIPP on cognition and neurodevelopment
de Vries, P. J., & Howe, C. J. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.06.003 · Cited by 84
Jozwiak, J., Jozwiak, S., Grzela, T., & Lazarczyk, M. (2005) · NeuroMolecular Medicine · doi:10.1385/nmm:7:4:287 · Cited by 63
“Also TSC2 missense mutations in the GAP domain associated with minimal clinical manifestations have been found and characterized in TSC patients (Mayer et al., 2004).”
Background
Metadata
- Authors
- Mayer, K., Goedbloed, M., van Zijl, K., Nellist, M., & Rott, H.-D.
- Venue
- Journal of Medical Genetics
- Publisher
- BMJ
- Published
- 2004-04-30
- Volume
- 41
- Issue
- 5
- Pages
- e64-e64
- ISSN
- 0022-2593 (ISSN-L)
- 1468-6244
- OpenAlex
- W2170030607
- Cited by
- 48
- References
- 3
- FWCI
- 1.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.